Hbsag Assay Laboratories manufactures the hbsag vlp vaccine reagents distributed by Genprice. The Hbsag Vlp Vaccine reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact hbsag assay. Other Hbsag products are available in stock. Specificity: Hbsag Category: Vlp Group: Vaccine
Anti-Norovirus (VLP from GII.4 VLP 1987-2009 and 2012) monoclonal antibody, clone C2048N |
Creative Diagnostics |
1 mg |
EUR 1251.6 |
HBe VLP Antibody |
ProSpec Tany |
100µg |
EUR 200 |
Description: Mouse Anti Hepatitis B Virus e-Virus Like Particle |
Human CLDN6 VLP |
EnoGene |
100 μg |
EUR 2400 |
Mayaro Virus VLP |
The Native Antigen Company |
0.1 |
EUR 641.71 |
Description: Recombinant Mayaro Virus-Like Particles produced in 293 human cells. Mayaro structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are tota |
Mayaro Virus VLP |
The Native Antigen Company |
0.025 |
EUR 302.36 |
Description: Recombinant Mayaro Virus-Like Particles produced in 293 human cells. Mayaro structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are total |
Mayaro Virus VLP |
The Native Antigen Company |
0.5 |
EUR 2468.58 |
Description: Recombinant Mayaro Virus-Like Particles produced in 293 human cells. Mayaro structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are total |
O'nyong'nyong Virus VLP |
The Native Antigen Company |
0.5 |
EUR 2311.66 |
Description: Recombinant O’nyong’nyong virus-like particles produced in 293 human cells. O’nyong’nyong structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are non-infectious. |
Vaccine information
Peptidoglycan (S. aureus); vaccine adjuvant |
AV-7045-5 |
Alpha Diagnostics |
5 mg |
EUR 343.2 |
Pam3CSK4 vaccine adjuvant; Biotin labelled |
AV-9025-B |
Alpha Diagnostics |
100 ug |
EUR 416.4 |
Pam2CSK4 vaccine adjuvant; Biotin conjugate |
AV-9020-B |
Alpha Diagnostics |
1 mg |
EUR 489.6 |
Pam2CSK4 vaccine adjuvant; Biotin conjugate |
AV-9020-B-100 |
Alpha Diagnostics |
100 ug |
EUR 196.8 |
HER2 peptide, (369 ?377), E75 vaccine candidate |
HER2-369-P |
Alpha Diagnostics |
5 mg |
EUR 416.4 |
HER2 peptide, (654 ? 662), GP2 vaccine candidate |
HER2-654-P |
Alpha Diagnostics |
5 mg |
EUR 416.4 |
Purified Cholera Toxin protein; vaccine grade |
AV-9135-1000 |
Alpha Diagnostics |
1 mg |
EUR 781.2 |
Purified Cholera Toxin protein; vaccine grade |
AV-9135-500 |
Alpha Diagnostics |
500 ug |
EUR 416.4 |
Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%; |
AV-4020-100 |
Alpha Diagnostics |
100 mg |
EUR 196.8 |
Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%; |
AV-4020-1000 |
Alpha Diagnostics |
1 g |
EUR 634.8 |
HER2 multi peptide, (776-790,927-941,1116-1180); vaccine candidate |
HER2-MP2 |
Alpha Diagnostics |
5 mg |
EUR 781.2 |
HER2 multi peptide, (42-56,98-114,328-345); vaccine candidate |
HER2-MP3 |
Alpha Diagnostics |
5 mg |
EUR 634.8 |
Complete Freund?s Adjuvant (CFA);vaccine adjuvant |
AV-3010-10 |
Alpha Diagnostics |
10 ml |
EUR 343.2 |
Complete Freund?s Adjuvant (CFA);vaccine adjuvant |
AV-3010-100 |
Alpha Diagnostics |
10x10 ml |
EUR 489.6 |